Cancer Rep-Us
Cancer Reports (abbreviated as *Cancer Rep-Us*; ISSN: 2573-8348) is a peer-reviewed, open access journal dedicated to the rapid dissemination of high-quality research across all disciplines of oncology. The journal’s scope encompasses a broad spectrum of cancer-related topics, including basic tumor biology, translational medicine, clinical trials, epidemiology, prevention, diagnosis, and treatment. It welcomes a variety of article types, such as original research articles, comprehensive reviews, short communications, case reports, and methodological papers, with a particular emphasis on studies that offer novel insights or practical applications in cancer care. The target audience includes academic researchers, clinical oncologists, medical students, and healthcare professionals seeking timely updates on cancer science and practice. Published by Wiley, the journal operates under a fully open access model, ensuring that all content is freely available to readers worldwide, which enhances the visibility and impact of published work. With a 2026 Journal Citation Reports Impact Factor of 2.500, *Cancer Reports* is positioned in the Q3 quartile within the oncology category (classified as 4区医学 in Chinese journal rankings). While not among the highest-tier oncology journals, its stable indexing and open access nature make it a valuable venue for researchers aiming to share findings with a global audience without subscription barriers, particularly for studies that may benefit from rapid publication and broad dissemination. The journal maintains rigorous peer review to uphold scientific integrity, serving as a practical resource for the oncology community.